Smoking Cessation for Hospital Employees With Low Education. (RESPEKT)
Smoking Cessation for Hospital Employees With Low Education in the Capital Region of Denmark. The RESPEKT Study.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The target group of this trial is smokers with low education working in hospitals in the Capital Region of Denmark.
The aim is to develop a new tailored smoking cessation program for and together with smokers with low education. We selected following seven positions/occupations as proxy for low socioeconomic status: cleaner, porter, kitchen staff, social and health care assistant, service assistant, technical staff and medial secretary.
In first step the investigators perform focus group interviews with the target group to identify wishes and barriers. In next step the investigators design the new tailored smoking cessation program together with smokers with low education.
Then the investigators test the effect of the smoking cessation program in a randomised controlled trial. All hospitals in the Capital Region of Denmark except one are included (the last hospital is situated on a remote island). Half of the hospitals are randomised to be intervention group and the other half is control group. Recruitment will be by written invitations, posters and primarily by peer-recruitment (smokers with low education who are ambassadors for the project at the work places). Posters and written invitations show photos of the ambassadors in the target group and their statements; why they have decided to quit smoking.
The group-based smoking cessation intervention is designed with guidance from the anchor persons. There is no moralizing or disease-focusing, few written materials and a lot of drawings and humor. The intervention will be in small groups (4-6 persons), with six sessions (á 1½-2 hours) taking place at the workplace during working time. All counsellors are ex-smokers. Stress-management is included at each session. We offer free nicotine products or varenicline by choice, for up to 12 weeks. Nicotine replacement therapy is always based on the patch and combined with inhaler or mouth spray p.n. Nicotine gum is not offered.
The investigators measure validated abstinence rates at each session and 6 months after last session.
Main end-point is smoking rates after 12 months in intervention hospitals compared with smoking rates in control hospitals.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Glostrup, Dinamarca, 2600
- Research Center for Prevention and Health
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria: employee with low education working in an intervention hospital in the Capital Region of Denmark.
We selected following seven positions/occupations as proxy for low socioeconomic status: cleaner, porter, kitchen staff, social and health care assistant, service assistant, technical staff and medial secretary.
-
Exclusion Criteria:
- does not speak Danish
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Targeted smoking cessation
Smoking cessation program tailored in cooperation with the target group; smokers with low education. Peer-based anti-relapse strategy. Recruitment strategy: peer-driven, written invitations and posters. |
Smoking cessation program developed in cooperation with and aimed at smokers with low education.
Otros nombres:
|
|
Sin intervención: Control
No smoking cessation program.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Smoking rate in hospitals randomised to intervention or control group
Periodo de tiempo: 12 months
|
Self-reported point abstinence
|
12 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Smoking cessation rate in persons participating in the group-based intervention
Periodo de tiempo: 6 months
|
Self-reported point abstinence + carbonmonoxide validated abstinence
|
6 months
|
|
Smoking cessation rate in persons participating in the intervention
Periodo de tiempo: 6 weeks after fixed quit date
|
Carbonmonoxide validated abstinence
|
6 weeks after fixed quit date
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Charlotta Pisinger, MD PhD MPH, Research Center for Prevention and Health
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- F-51061
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Targeted smoking cessation
-
Endourage, LLCReclutamientoSeguimiento de síntomas en pacientes con COVID prolongado que utilizan gotas sublinguales Formula C™COVID largo | Largo Covid19 | COVID-19 posagudo | Larga distancia COVID | Larga distancia COVID-19 | Síndrome post-agudo de COVID-19Estados Unidos
-
Endourage, LLCTerminado
-
He HuangYake Biotechnology Ltd.ReclutamientoRecaído y Refractario | Neoplasias malignas hematológicas linfoidesPorcelana
-
University of Wisconsin, MadisonUniversity of Illinois at Chicago; Penn State UniversityTerminado